COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in Additional Funding
Spiden, a pioneer in non-invasive biomarker monitoring technology, has reached an important scientific milestone in non-invasive glucose sensing technology. The company has also made significant additions to its executive team, secured an oversubscribed convertible note, and commenced measurements in diabetes centers in multiple countries. Spiden aims to launch its non-invasive glucose monitoring wearable by the end of 2025 and expand to other biomarkers, setting a new standard in personalized health monitoring. -
COMMUNIQUÉ RÉGLEMENTÉ
SHARE CAPITAL AND COMPUTATION OF VOTING RIGHTS AS AT 31.12.23
This press release contains the declaration related to the number of voting rights and shares comprising the share capital of MANITOU BF in compliance with the article 223-16 of the General Regulation of the Financial Markets Authority (AMF - Autorité des Marchés Financiers). It provides details of the share capital, share value, and the number of theoretical and effective voting rights for shareholders' meetings. Additionally, it outlines the obligation for individuals or entities holding over 1% of the share capital or voting rights to inform the company and provides contact information for shareholder information. -
COMMUNIQUÉ RÉGLEMENTÉ
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE AU 31.12.23
Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société Manitou BF conformément à l'article 223-16 du Règlement Général de l’Autorité des Marchés Financiers -
COMMUNIQUÉ DE PRESSE
Top Alternative Investment Trends to Watch for in 2024
Learn about the top alternative investment trends to watch for in 2024, including private equity, real estate, cryptocurrencies, commodities, art, private credit, and peer-to-peer lending. These investments offer opportunities for diversification and potentially improved returns, providing a hedge against market volatility and economic instability. Explore the potential of these up-trending options to enhance your investment portfolio. -
COMMUNIQUÉ DE PRESSE
Electrovaya to Participate in the iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas Virtual Conference on January 9th and 10th, 2024
Electrovaya Inc., a leading lithium-ion battery technology and manufacturing company, will be participating in the iAccess Alpha Tax Loss Recovery Summit Virtual Conference on January 9th and 10th, 2024. Dr. Raj DasGupta, Electrovya's CEO, will be delivering a company presentation and hosting one-on-one meetings during the conference. For more information and to register for the conference, please visit the event website. A webcast of the presentation will also be available at the provided link. Contact details for investors and media are included in the press release. Electrovaya Inc. is a pioneering leader in the global energy transformation, focusing on contributing to preventing climate change by supplying safe and long-lasting lithium-ion batteries. The Company also develops next generation solid state battery technology. For more information about Electrovaya, please visit their website. -
COMMUNIQUÉ RÉGLEMENTÉ
Bilan semestriel du contrat de liquidité entre Interparfums et Oddo BHF SCA
-
COMMUNIQUÉ RÉGLEMENTÉ
Half-yearly report on the liquidity contract between Interparfums and Oddo BHF SCA
XYZ Company announces new investment opportunities in renewable energy projects. The company aims to provide sustainable investment options for individuals and institutions looking to support clean energy initiatives. -
-
COMMUNIQUÉ DE PRESSE
Metrodora Institute Announces New Chief Scientific Officer
Metrodora Institute, a leading multispecialty healthcare institute, announces the hiring of Rohit Gupta, a nationally recognized scientist, biobank, and data expert, as its new Chief Scientific Officer and Head of R&D. Gupta's extensive experience and expertise in leading research enterprises and developing innovative medical technology make him a valuable addition to the institute. His vision and leadership will accelerate Metrodora's goals of developing and adopting new solutions to improve the lives of the patients they serve. Located in Salt Lake City, Utah, Metrodora Institute was founded in 2021 with the vision of reimagining care for patients with complex multisystem disorders, treating neurological, gastrointestinal, immunological, autoimmune, pain, and metabolic disorders.
